RecruitingParoxysmal Atrial FibrillationPersistent Atrial Fibrillation

Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Eligible age

18+ yrs

Accepts

All genders

Locations

31 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term, effectiveness of catheter ablation with novel RF technologies in PAF and PsAF patients.

Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

You may qualify if…

✓ Symptomatic Paroxysmal (AF episode terminate spontaneously within 7 days) or Persistent (AF sustained beyond 7 days) who, in the opinion of the investigator, are candidates for ablation for AF
✓ 18 years of age or older
✓ De Novo ablation procedure unless it is a repeat for a patient whose index procedure is also in the registry
✓ Able and willing to participate in baseline and follow up evaluations for the full length of the registry
✓ Willing and able to provide informed consent, if applicable

You may not qualify if…

✕ Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
✕ Long-standing persistent AF (AF greater than one year's duration)
✕ Having a repeat ablation, unless the subject's index ablation procedure is also included in the registry
✕ In the opinion of the investigator, any known contraindication to an ablation procedure